← Back to catalogue

Thyretain

FDA UDI

Class II (US FDA UDI)

by Diagnostic Hybrids, Inc.

Identity

Trade Name
Thyretain FDA UDI
Generic Name
Thyroid stimulating hormone receptor (TSHR) antibody IVD, kit, bioassay FDA UDI
Device Name
THYRETAIN CELL & Control SET FDA UDI
Model / Reference
40-1005K.V2 FDA UDI
Description
THYRETAIN CELL & Control SET FDA UDI

Identifiers

Catalog Number
40-1005K.V2 FDA UDI
Primary DI / UDI-DI
30014613331490 FDA UDI
FDA Product Code
JZO FDA UDI
GMDN Term
Thyroid stimulating hormone receptor (TSHR) antibody IVD, kit, bioassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5870 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Thyroid stimulating hormone receptor (TSHR) antibody IVD, kit, bioassay

Thyretain by Diagnostic Hybrids, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Thyroid stimulating hormone receptor (TSHR) antibody IVD, kit, bioassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diagnostic Hybrids, Inc.

Sources (1)

  • FDA UDI 3d6814af-8c01-4a27-b1a0-7fecb737f375 35 fields · synced May 30, 2026